Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Behavioural Neurology
Volume 2016, Article ID 8781725, 14 pages
http://dx.doi.org/10.1155/2016/8781725
Review Article

Pediatric Traumatic Brain Injury and Autism: Elucidating Shared Mechanisms

1Department of Neurosurgery, West Virginia University School of Medicine, Morgantown, WV 26505, USA
2Department of Basic Pharmaceutical Sciences, West Virginia University School of Medicine, Morgantown, WV 26505, USA
3Department of Medical Sciences, University of Florida School of Medicine, Gainesville, FL 32611, USA
4Department of Psychology, North Carolina State University, Raleigh, NC 27695, USA

Received 2 October 2016; Accepted 23 November 2016

Academic Editor: Akin Ojagbemi

Copyright © 2016 Rahul Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Weintraub, “The prevalence puzzle: autism counts,” Nature, vol. 479, no. 7371, pp. 22–24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M.-C. Lai, M. V. Lombardo, and S. Baron-Cohen, “Autism,” The Lancet, vol. 383, no. 9920, pp. 896–910, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. S. S.-H. Wang, A. D. Kloth, and A. Badura, “The cerebellum, sensitive periods, and autism,” Neuron, vol. 83, no. 3, pp. 518–532, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Bakker, C. Catroppa, and V. Anderson, “Olfactory dysfunction in pediatric traumatic brain injury: a systematic review,” Journal of Neurotrauma, vol. 31, no. 4, pp. 308–314, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. C. J. Newschaffer, L. A. Croen, J. Daniels et al., “The epidemiology of autism spectrum disorders,” Annual Review of Public Health, vol. 28, pp. 235–258, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Barlow, E. Thompson, D. Johnson, and R. A. Minns, “The neurological outcome of non-accidental head injury,” Pediatric Rehabilitation, vol. 7, no. 3, pp. 195–203, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. R. L. Peterson, A. K. Connery, D. A. Baker, and M. W. Kirkwood, “Preinjury emotional-behavioral functioning of children with lingering problems after mild traumatic brain injury,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 27, no. 4, pp. 280–286, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Ozgen, G. S. Hellemann, R. K. Stellato et al., “Morphological features in children with autism spectrum disorders: a matched case-control study,” Journal of Autism and Developmental Disorders, vol. 41, no. 1, pp. 23–31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. B. Brown and J. H. Elder, “Communication in autism spectrum disorder: a guide for pediatric nurses,” Pediatric Nursing, vol. 40, no. 5, pp. 219–225, 2014. View at Google Scholar · View at Scopus
  10. K. F. Linton and B. J. Kim, “Traumatic brain injury as a result of violence in native American and black communities spanning from childhood to older adulthood,” Brain Injury, vol. 28, no. 8, pp. 1076–1081, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. N. C. Collins, M. Molcho, P. Carney et al., “Are boys and girls that different? An analysis of traumatic brain injury in children,” Emergency Medicine Journal, vol. 30, no. 8, pp. 675–678, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Brain Trauma Foundation, American Association of Neurological Surgeons, and Congress of Neurological Surgeons, “Guidelines for the management of severe traumatic brain injury,” Journal of Neurotrauma, vol. 24, supplement 1, pp. S1–S106, 2007. View at Publisher · View at Google Scholar
  13. D. Radice-Neumann, B. Zupan, D. R. Babbage, and B. Willer, “Overview of impaired facial affect recognition in persons with traumatic brain injury,” Brain Injury, vol. 21, no. 8, pp. 807–816, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Gorman, M. A. Barnes, P. R. Swank, M. Prasad, and L. Ewing-Cobbs, “The effects of pediatric traumatic brain injury on verbal and visual-spatial working memory,” Journal of the International Neuropsychological Society, vol. 18, no. 1, pp. 29–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. P. R. Karunanayaka, S. K. Holland, W. Yuan et al., “Neural substrate differences in language networks and associated language-related behavioral impairments in children with TBI: a preliminary fMRI investigation,” NeuroRehabilitation, vol. 22, no. 5, pp. 355–369, 2007. View at Google Scholar · View at Scopus
  16. T. Power, C. Catroppa, L. Coleman, M. Ditchfield, and V. Anderson, “Do lesion site and severity predict deficits in attentional control after preschool traumatic brain injury (TBI)?” Brain Injury, vol. 21, no. 3, pp. 279–292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Taghizadeh, A. Davidson, K. Williams, and D. Story, “Autism spectrum disorder (ASD) and its perioperative management,” Paediatric Anaesthesia, vol. 25, no. 11, pp. 1076–1084, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. B. A. Church, C. L. Rice, A. Dovgopoly et al., “Learning, plasticity, and atypical generalization in children with autism,” Psychonomic Bulletin and Review, vol. 22, no. 5, pp. 1342–1348, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Blackmon, “Structural MRI biomarkers of shared pathogenesis in autism spectrum disorder and epilepsy,” Epilepsy and Behavior, vol. 47, pp. 172–182, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. Y.-S. Chang, J. P. Owen, S. S. Desai et al., “Autism and sensory processing disorders: shared white matter disruption in sensory pathways but divergent connectivity in social-emotional pathways,” PLOS ONE, vol. 9, no. 7, Article ID e103038, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Spreckley and R. Boyd, “Efficacy of applied behavioral intervention in preschool children with autism for improving cognitive, language, and adaptive behavior: a systematic review and meta-analysis,” Journal of Pediatrics, vol. 154, no. 3, pp. 338–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Jacquemont, A. Curie, V. des Portes et al., “Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056,” Science Translational Medicine, vol. 3, no. 64, Article ID 64ra1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. G. Chez, Q. Burton, T. Dowling, M. Chang, P. Khanna, and C. Kramer, “Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability,” Journal of Child Neurology, vol. 22, no. 5, pp. 574–579, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. A. Erickson, D. J. Posey, K. A. Stigler, J. Mullett, A. R. Katschke, and C. J. McDougle, “A retrospective study of memantine in children and adolescents with pervasive developmental disorders,” Psychopharmacology, vol. 191, no. 1, pp. 141–147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Ghaleiha, M. Asadabadi, M.-R. Mohammadi et al., “Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial,” International Journal of Neuropsychopharmacology, vol. 16, no. 4, pp. 783–789, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Owley, J. Salt, S. Guter et al., “A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders,” Journal of Child and Adolescent Psychopharmacology, vol. 16, no. 5, pp. 517–524, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. C. A. Erickson, J. E. Mullett, and C. J. McDougle, “Open-label memantine in fragile X syndrome,” Journal of Autism and Developmental Disorders, vol. 39, no. 12, pp. 1629–1635, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. E. M. Berry-Kravis, D. Hessl, B. Rathmell et al., “Effects of STX209 (Arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial,” Science Translational Medicine, vol. 4, no. 152, Article ID 152ra127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. C. A. Erickson, J. M. Veenstra-Vanderweele, R. D. Melmed et al., “STX209 (Arbaclofen) for autism spectrum disorders: an 8-week open-label study,” Journal of Autism and Developmental Disorders, vol. 44, no. 4, pp. 958–964, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. C. A. Erickson, M. Early, K. A. Stigler, L. K. Wink, J. E. Mullett, and C. J. McDougle, “An open-label naturalistic pilot study of acamprosate in youth with autistic disorder,” Journal of Child and Adolescent Psychopharmacology, vol. 21, no. 6, pp. 565–569, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. C. A. Erickson, J. E. Mullett, and C. J. McDougle, “Brief report: acamprosate in fragile X syndrome,” Journal of Autism and Developmental Disorders, vol. 40, no. 11, pp. 1412–1416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. C. A. Erickson, L. K. Wink, B. Ray et al., “Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome,” Psychopharmacology, vol. 228, no. 1, pp. 75–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. Erickson, L. K. Wink, M. C. Early et al., “Brief report: pilot single-blind placebo lead-in study of acamprosate in youth with autistic disorder,” Journal of Autism and Developmental Disorders, vol. 44, no. 4, pp. 981–987, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. M. R. Dadds, E. MacDonald, A. Cauchi, K. Williams, F. Levy, and J. Brennan, “Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial,” Journal of Autism and Developmental Disorders, vol. 44, no. 3, pp. 521–531, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Hollander, J. Bartz, W. Chaplin et al., “Oxytocin increases retention of social cognition in autism,” Biological Psychiatry, vol. 61, no. 4, pp. 498–503, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. J. Guastella, S. L. Einfeld, K. M. Gray et al., “Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders,” Biological Psychiatry, vol. 67, no. 7, pp. 692–694, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Hollander, S. Novotny, M. Hanratty et al., “Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders,” Neuropsychopharmacology, vol. 28, no. 1, pp. 193–198, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Andari, J.-R. Duhamel, T. Zalla, E. Herbrecht, M. Leboyer, and A. Sirigu, “Promoting social behavior with oxytocin in high-functioning autism spectrum disorders,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 9, pp. 4389–4394, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Anagnostou, L. Soorya, W. Chaplin et al., “Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial,” Molecular Autism, vol. 3, article no. 16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Y. Hardan and B. L. Handen, “A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder,” Journal of Child and Adolescent Psychopharmacology, vol. 12, no. 3, pp. 237–241, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. B. L. Handen, C. R. Johnson, S. McAuliffe-Bellin, P. J. Murray, and A. Y. Hardan, “Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures,” Journal of Child and Adolescent Psychopharmacology, vol. 21, no. 1, pp. 43–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Hertzman, “Galantamine in the treatment of adult autism: a report of three clinical cases,” The International Journal of Psychiatry in Medicine, vol. 33, no. 4, pp. 395–398, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. M. G. Chez, M. Aimonovitch, T. Buchanan, S. Mrazek, and R. J. Tremb, “Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate,” Journal of Child Neurology, vol. 19, no. 3, pp. 165–169, 2004. View at Google Scholar · View at Scopus
  44. P. D. Patrick, M. L. Buck, M. R. Conaway, and J. A. Blackman, “The use of dopamine enhancing medications with children in low response states following brain injury,” Brain Injury, vol. 17, no. 6, pp. 497–506, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. P. D. Patrick, J. A. Blackman, J. L. Mabry, M. L. Buck, M. J. Gurka, and M. R. Conaway, “Dopamine agonist therapy in low-response children following traumatic brain injury,” Journal of Child Neurology, vol. 21, no. 10, pp. 879–885, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. L. B. Green, J. E. Hornyak, and E. A. Hurvitz, “Amantadine in pediatric patients with traumatic brain injury: a retrospective, case-controlled study,” American Journal of Physical Medicine and Rehabilitation, vol. 83, no. 12, pp. 893–897, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. S. E. Williams, M. D. Ris, R. Ayyangar, B. K. Schefft, and D. Berch, “Recovery in pediatric brain injury: is psychostimulant medication beneficial?” Journal of Head Trauma Rehabilitation, vol. 13, no. 3, pp. 73–81, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Trovato, B. Slomine, F. Pidcock, and J. Christensen, “The efficacy of donepezil hydrochloride on memory functioning in three adolescents with severe traumatic brain injury,” Brain Injury, vol. 20, no. 3, pp. 339–343, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. P. L. Pearl, R. McCarter, C. L. McGavin et al., “Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy,” Epilepsia, vol. 54, no. 9, pp. e135–e137, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. B. Young, R. P. Rapp, J. A. Norton, D. Haack, and J. W. Walsh, “Failure of prophylactically administered phenytoin to prevent post-traumatic seizures in children,” Child's Brain, vol. 10, no. 3, pp. 185–192, 1983. View at Google Scholar · View at Scopus
  51. G. Teasdale and B. Jennett, “Assessment of coma and impaired consciousness. A practical scale,” The Lancet, vol. 304, no. 7872, pp. 81–84, 1974. View at Publisher · View at Google Scholar · View at Scopus
  52. S. R. Beers, S. R. Wisniewski, P. Garcia-Filion et al., “Validity of a pediatric version of the glasgow outcome scale-extended,” Journal of Neurotrauma, vol. 29, no. 6, pp. 1126–1139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Arienta, M. Caroli, and S. Balbi, “Management of head-injured patients in the emergency department: a practical protocol,” Surgical Neurology, vol. 48, no. 3, pp. 213–219, 1997. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Bullock, R. M. Chesnut, G. Clifton et al., “Guidelines for the management of severe head injury,” European Journal of Emergency Medicine, vol. 3, no. 2, pp. 109–127, 1996. View at Publisher · View at Google Scholar · View at Scopus
  55. M. R. Bullock, R. Chesnut, J. Ghajar et al., “Surgical management of traumatic parenchymal lesions,” Neurosurgery, vol. 58, supplement 3, pp. S25–S46, 2006. View at Google Scholar
  56. M. R. Bullock, R. Chesnut, J. Ghajar et al., “Surgical management of acute epidural hematomas,” Neurosurgery, vol. 58, no. 3, pp. S7–S15, 2006. View at Google Scholar · View at Scopus
  57. M. R. Bullock, R. Chesnut, J. Ghajar et al., “Surgical management of acute subdural hematomas,” Neurosurgery, vol. 58, no. 3, pp. S216–S224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Baird, H. Cass, and V. Slonims, “Diagnosis of autism,” British Medical Journal, vol. 327, no. 7413, pp. 488–493, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. P. A. Filipek, P. J. Accardo, S. Ashwal et al., “Practice parameter: screening and diagnosis of autism: report of the quality standards subcommittee of the American Academy of Neurology and the Child Neurology Society,” Neurology, vol. 55, no. 4, pp. 468–479, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Lanfranconi, G. Franco, L. Borellini et al., “Genetics of cerebral hemorrhage and microbleeds,” Panminerva Medica, vol. 55, no. 1, pp. 11–28, 2013. View at Google Scholar · View at Scopus
  61. K. Singh and A. W. Zimmerman, “Sleep in autism spectrum disorder and attention deficit hyperactivity disorder,” Seminars in Pediatric Neurology, vol. 22, no. 2, pp. 113–125, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. C. S. Rosenfeld, “Microbiome disturbances and autism spectrum disorders,” Drug Metabolism & Disposition, vol. 43, no. 10, pp. 1557–1571, 2015. View at Publisher · View at Google Scholar
  63. M. Carabotti, A. Scirocco, M. A. Maselli, and C. Severi, “The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems,” Annals of Gastroenterology, vol. 28, no. 2, pp. 203–209, 2015. View at Google Scholar · View at Scopus
  64. M. Douglas-Escobar, E. Elliott, and J. Neu, “Effect of intestinal microbial ecology on the developing brain,” JAMA Pediatrics, vol. 167, no. 4, pp. 374–379, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. R. K. Naviaux, “Metabolic features of the cell danger response,” Mitochondrion, vol. 16, pp. 7–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. K. Babinska, M. Bucova, V. Durmanova et al., “Increased plasma levels of the high mobility group box 1 protein (HMGB1) are associated with a higher score of gastrointestinal dysfunction in individuals with autism,” Physiological Research, vol. 63, supplement 4, pp. S613–S618, 2014. View at Google Scholar
  67. M. Samsam, R. Ahangari, and S. A. Naser, “Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance,” World Journal of Gastroenterology, vol. 20, no. 29, pp. 9942–9951, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. M. M. H. van De Sande, V. J. van Buul, and F. J. P. H. Brouns, “Autism and nutrition: the role of the gut-brain axis,” Nutrition Research Reviews, vol. 27, no. 2, pp. 199–214, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. E. A. Mayer, D. Padua, and K. Tillisch, “Altered brain-gut axis in autism: comorbidity or causative mechanisms?” BioEssays, vol. 36, no. 10, pp. 933–939, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. A. P. Hill, J. van Santen, K. Gorman, B. H. Langhorst, and E. Fombonne, “Memory in language-impaired children with and without autism,” Journal of Neurodevelopmental Disorders, vol. 7, article 19, 2015. View at Publisher · View at Google Scholar
  71. H. B. Cygan, P. Tacikowski, P. Ostaszewski, I. Chojnicka, and A. Nowicka, “Neural correlates of own name and own face detection in autism spectrum disorder,” PLoS ONE, vol. 9, no. 1, Article ID e86020, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. D. J. Greene, N. Colich, M. Iacoboni, E. Zaidel, S. Y. Bookheimer, and M. Dapretto, “Atypical neural networks for social orienting in autism spectrum disorders,” NeuroImage, vol. 56, no. 1, pp. 354–362, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. P. Jedlicka, M. Vnencak, D. D. Krueger, T. Jungenitz, N. Brose, and S. W. Schwarzacher, “Neuroligin-1 regulates excitatory synaptic transmission, LTP and EPSP-spike coupling in the dentate gyrus in vivo,” Brain Structure and Function, vol. 220, no. 1, pp. 47–58, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. T. J. Ornstein, S. Sagar, R. J. Schachar et al., “Neuropsychological performance of youth with secondary attention-deficit/hyperactivity disorder 6- and 12-months after traumatic brain injury,” Journal of the International Neuropsychological Society, vol. 20, no. 10, pp. 971–981, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Gorman, M. A. Barnes, P. R. Swank, M. Prasad, and C. S. Cox, “Does processing speed mediate the effect of pediatric traumatic brain injury on working memory?” Neuropsychology, vol. 30, no. 3, pp. 263–273, 2016. View at Publisher · View at Google Scholar
  76. R. Moretti, J. Pansiot, D. Bettati et al., “Blood-brain barrier dysfunction in disorders of the developing brain,” Frontiers in Neuroscience, vol. 9, article 40, 2015. View at Publisher · View at Google Scholar · View at Scopus
  77. J. H. Coyne, J. M. Borg, J. Deluca, L. Glass, and J. F. Sumowski, “Retrieval practice as an effective memory strategy in children and adolescents with traumatic brain injury,” Archives of Physical Medicine and Rehabilitation, vol. 96, no. 4, pp. 742–745, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Aida, J. Yoshida, M. Nomura et al., “Astroglial glutamate transporter deficiency increases synaptic excitability and leads to pathological repetitive behaviors in mice,” Neuropsychopharmacology, vol. 40, no. 7, pp. 1569–1579, 2015. View at Publisher · View at Google Scholar · View at Scopus
  79. M. R. Williams, T. De-Spenza Jr., M. Li, A. T. Gulledge, and B. W. Luikart, “Hyperactivity of newborn pten knock-out neurons results from increased excitatory synaptic drive,” The Journal of Neuroscience, vol. 35, no. 3, pp. 943–959, 2015. View at Publisher · View at Google Scholar · View at Scopus
  80. K. Liesemer, S. L. Bratton, C. M. Zebrack, D. Brockmeyer, and K. D. Statler, “Early post-traumatic seizures in moderate to severe pediatric traumatic brain injury: rates, risk factors, and clinical features,” Journal of Neurotrauma, vol. 28, no. 5, pp. 755–762, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. N. Golden, S. Darmadipura, and N. A. Bagiada, “The difference in seizure incidences between young and adult rats related to lipid peroxidation after intracortical injection of ferric chloride,” Singapore Medical Journal, vol. 51, no. 2, pp. 105–109, 2010. View at Google Scholar · View at Scopus
  82. M. S. Bessisso, M. F. El-Said, N. A. Almula, S. B. Azzam, H. A. Sweid, and M. G. Al-Ali, “Risk of seizure recurrences after first unprovoked seizure during childhood,” Neurosciences, vol. 6, pp. 95–98, 2001. View at Google Scholar
  83. R. F. Hevner, “Brain overgrowth in disorders of RTK-PI3K-AKT signaling: a mosaic of malformations,” Seminars in Perinatology, vol. 39, no. 1, pp. 36–43, 2015. View at Publisher · View at Google Scholar · View at Scopus
  84. P. B. Bernard and T. A. Benke, “Early life seizures: evidence for chronic deficits linked to autism and intellectual disability across species and models,” Experimental Neurology, vol. 263, pp. 72–78, 2015. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Budday, C. Raybaud, and E. Kuhl, “A mechanical model predicts morphological abnormalities in the developing human brain,” Scientific Reports, vol. 4, article 5644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. J. M. Baruth, M. F. Casanova, L. Sears, and E. Sokhadze, “Early-Stage visual processing abnormalities in high-functioning autism spectrum disorder (asd),” Translational Neuroscience, vol. 1, no. 2, pp. 177–187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. M. F. Casanova, J. M. Baruth, A. El-Baz, A. Tasman, L. Sears, and E. Sokhadze, “Repetitive transcranial magnetic stimulation (rTMS) modulates event-related potential (ERP) indices of attention in autism,” Translational Neuroscience, vol. 3, no. 2, pp. 170–180, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. T. P. L. Roberts, S. Y. Khan, M. Rey et al., “MEG detection of delayed auditory evoked responses in autism spectrum disorders: towards an imaging biomarker for autism,” Autism Research, vol. 3, no. 1, pp. 8–18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. W. Liao, M. J. Gandal, R. S. Ehrlichman, S. J. Siegel, and G. C. Carlson, “MeCP2+/− mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder,” Neurobiology of Disease, vol. 46, pp. 88–92, 2012. View at Google Scholar
  90. T. M. DeLorey, P. Sahbaie, E. Hashemi, W.-W. Li, A. Salehi, and D. J. Clark, “Somatosensory and sensorimotor consequences associated with the heterozygous disruption of the autism candidate gene, Gabrb3,” Behavioural Brain Research, vol. 216, no. 1, pp. 36–45, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. N. Li, Y. Yang, D. P. Glover et al., “Evidence for impaired plasticity after traumatic brain injury in the developing brain,” Journal of Neurotrauma, vol. 31, no. 4, pp. 395–403, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Galvin, E. H. Froude, and C. Imms, “Sensory processing abilities of children who have sustained traumatic brain injuries,” American Journal of Occupational Therapy, vol. 63, no. 6, pp. 701–709, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. E. Glerean, R. K. Pan, J. Salmi et al., “Reorganization of functionally connected brain subnetworks in high-functioning autism,” Human Brain Mapping, vol. 37, no. 3, pp. 1066–1079, 2016. View at Publisher · View at Google Scholar · View at Scopus
  94. U. Roine, T. Roine, J. Salmi et al., “Abnormal wiring of the connectome in adults with high-functioning autism spectrum disorder,” Molecular Autism, vol. 6, article 65, 2015. View at Publisher · View at Google Scholar · View at Scopus
  95. C. C. Dougherty, D. W. Evans, S. M. Myers, G. J. Moore, and A. M. Michael, “A comparison of structural brain imaging findings in autism spectrum disorder and attention-deficit hyperactivity disorder,” Neuropsychology Review, vol. 26, no. 1, pp. 25–43, 2016. View at Publisher · View at Google Scholar · View at Scopus
  96. S. C. L. Deoni, J. R. Zinkstok, E. Daly et al., “White-matter relaxation time and myelin water fraction differences in young adults with autism,” Psychological Medicine, vol. 45, no. 4, pp. 795–805, 2015. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Lazar, L. M. Miles, J. S. Babb, and J. B. Donaldson, “Axonal deficits in young adults with high functioning autism and their impact on processing speed,” NeuroImage: Clinical, vol. 4, pp. 417–425, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. L. Cerliani, M. Mennes, R. M. Thomas, A. Di Martino, M. Thioux, and C. Keysers, “Increased functional connectivity between subcortical and cortical resting-state networks in Autism spectrum disorder,” JAMA Psychiatry, vol. 72, no. 8, pp. 767–777, 2015. View at Publisher · View at Google Scholar · View at Scopus
  99. E. L. Dennis, Y. Jin, J. E. Villalon-Reina et al., “White matter disruption in moderate/severe pediatric traumatic brain injury: advanced tract-based analyses,” NeuroImage: Clinical, vol. 7, pp. 493–505, 2015. View at Publisher · View at Google Scholar · View at Scopus
  100. P. Kourtidou, S. R. McCauley, E. D. Bigler et al., “Centrum semiovale and corpus callosum integrity in relation to information processing speed in patients with severe traumatic brain injury,” Journal of Head Trauma Rehabilitation, vol. 28, no. 6, pp. 433–441, 2013. View at Publisher · View at Google Scholar · View at Scopus
  101. B. L. Bartnik-Olson, B. Holshouser, H. Wang et al., “Impaired neurovascular unit function contributes to persistent symptoms after concussion: a pilot study,” Journal of Neurotrauma, vol. 31, no. 17, pp. 1497–1506, 2014. View at Publisher · View at Google Scholar · View at Scopus
  102. T. C. Wu, E. A. Wilde, E. D. Bigler et al., “Longitudinal changes in the corpus callosum following pediatric traumatic brain injury,” Developmental Neuroscience, vol. 32, no. 5-6, pp. 361–373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. J. V. Hunter, E. A. Wilde, K. A. Tong, and B. A. Holshouser, “Emerging imaging tools for use with traumatic brain injury research,” Journal of Neurotrauma, vol. 29, no. 4, pp. 654–671, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. M. H. Beauchamp, R. Beare, M. Ditchfield et al., “Susceptibility weighted imaging and its relationship to outcome after pediatric traumatic brain injury,” Cortex, vol. 49, no. 2, pp. 591–598, 2013. View at Publisher · View at Google Scholar · View at Scopus
  105. S. J. Suskauer and T. A. G. M. Huisman, “Neuroimaging in pediatric traumatic brain injury: current and future predictors of functional outcome,” Developmental Disabilities Research Reviews, vol. 15, no. 2, pp. 117–123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. M. Königs, W. D. Weeda, L. W. E. van Heurn et al., “Impaired visual integration in children with traumatic brain injury: an observational study,” PLoS ONE, vol. 10, no. 12, Article ID e0144395, 2015. View at Publisher · View at Google Scholar · View at Scopus
  107. F. K. Korley, R. Diaz-Arrastia, A. H. B. Wu et al., “Circulating brain-derived neurotrophic factor has diagnostic and prognostic value in traumatic brain injury,” Journal of Neurotrauma, vol. 33, no. 2, pp. 215–225, 2016. View at Publisher · View at Google Scholar · View at Scopus
  108. D. Granpeesheh, J. Tarbox, and D. R. Dixon, “Applied behavior analytic interventions for children with autism: a description and review of treatment research,” Annals of Clinical Psychiatry, vol. 21, no. 3, pp. 162–173, 2009. View at Google Scholar · View at Scopus
  109. M. L. Sundberg and J. Michael, “The benefits of Skinner's analysis of verbal behavior for children with autism,” Behavior Modification, vol. 25, no. 5, pp. 698–724, 2001. View at Publisher · View at Google Scholar · View at Scopus
  110. D. M. Baer, M. M. Wolf, and T. R. Risley, “Some current dimensions of applied behavior analysis,” Journal of Applied Behavior Analysis, vol. 1, no. 1, pp. 91–97, 1968. View at Publisher · View at Google Scholar
  111. L. Y. Tsai, “Brief report: comorbid psychiatric disorders of autistic disorder,” Journal of Autism and Developmental Disorders, vol. 26, no. 2, pp. 159–163, 1996. View at Publisher · View at Google Scholar · View at Scopus
  112. M. L. Sundberg, B. S. Juan, M. Dawdy, and M. Arguelles, “The acquisition of tacts, mands, and intraverbals by individuals with traumatic brain injury,” The Analysis of Verbal Behavior, vol. 8, pp. 83–99, 1990. View at Google Scholar
  113. A. M. Steiner, G. W. Gengoux, A. Klin, and K. Chawarska, “Pivotal response treatment for infants at-risk for autism spectrum disorders: a pilot study,” Journal of Autism and Developmental Disorders, vol. 43, no. 1, pp. 91–102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  114. F. Mohammadzaheri, L. K. Koegel, M. Rezaei, and E. Bakhshi, “A randomized clinical trial comparison between Pivotal Response Treatment (PRT) and adult-driven Applied Behavior Analysis (ABA) intervention on disruptive behaviors in public school children with autism,” Journal of Autism and Developmental Disorders, vol. 45, no. 9, pp. 2899–2907, 2015. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Ylvisaker, L. Turkstra, C. Coehlo et al., “Behavioural interventions for children and adults with behaviour disorders after TBI: a systematic review of the evidence,” Brain Injury, vol. 21, no. 8, pp. 769–805, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. S. L. Wade, H. G. Taylor, A. Cassedy et al., “Long-term behavioral outcomes after a randomized, clinical trial of counselor-assisted problem solving for adolescents with complicated mild-to-severe traumatic brain injury,” Journal of Neurotrauma, vol. 32, no. 13, pp. 967–975, 2015. View at Publisher · View at Google Scholar · View at Scopus
  117. J. L. Matson and J. Jang, “Treating aggression in persons with autism spectrum disorders: a review,” Research in Developmental Disabilities, vol. 35, no. 12, pp. 3386–3391, 2014. View at Publisher · View at Google Scholar · View at Scopus
  118. G. Dawson and R. Bernier, “A quarter century of progress on the early detection and treatment of autism spectrum disorder,” Development and Psychopathology, vol. 25, no. 4, pp. 1455–1472, 2013. View at Publisher · View at Google Scholar · View at Scopus
  119. S. Q. Mehta and P. Golshani, “Clinical neurogenetics: autism spectrum disorders,” Neurologic Clinics, vol. 31, no. 4, pp. 951–968, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. C. Farmer, A. Thurm, and P. Grant, “Pharmacotherapy for the core symptoms in autistic disorder: current status of the research,” Drugs, vol. 73, no. 4, pp. 303–314, 2013. View at Publisher · View at Google Scholar · View at Scopus
  121. M. L. McPheeters, Z. Warren, N. Sathe et al., “A systematic review of medical treatments for children with autism spectrum disorders,” Pediatrics, vol. 127, no. 5, pp. e1312–e1321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  122. P. A. J. Janssen, C. J. E. Niemegeers, F. Awouters, K. H. L. Schellekens, A. A. H. P. Megens, and T. F. Meert, “Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties,” Journal of Pharmacology and Experimental Therapeutics, vol. 244, no. 2, pp. 685–693, 1988. View at Google Scholar · View at Scopus
  123. J. E. Leysen, W. Gommeren, A. Eens, D. De Chaffoy de Courcelles, J. C. Stoof, and P. A. J. Janssen, “Biochemical profile of risperidone, a new antipsychotic,” Journal of Pharmacology and Experimental Therapeutics, vol. 247, no. 2, pp. 661–670, 1988. View at Google Scholar · View at Scopus
  124. O. S. Jesner, M. Aref-Adib, and E. Coren, “Risperidone for autism spectrum disorder,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD005040, 2007. View at Google Scholar · View at Scopus
  125. J. T. McCracken, J. McGough, B. Shah et al., “Risperidone in children with autism and serious behavioral problems,” The New England Journal of Medicine, vol. 347, no. 5, pp. 314–321, 2002. View at Publisher · View at Google Scholar · View at Scopus
  126. C. J. McDougle, L. Scahill, M. G. Aman et al., “Risperidone for the core symptom domains of autism: results from the study by the Autism Network of the Research Units on Pediatric Psychopharmacology,” American Journal of Psychiatry, vol. 162, no. 6, pp. 1142–1148, 2005. View at Publisher · View at Google Scholar · View at Scopus
  127. S. Shea, A. Turgay, A. Carroll et al., “Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders,” Pediatrics, vol. 114, no. 5, pp. e634–e641, 2004. View at Publisher · View at Google Scholar · View at Scopus
  128. D. A. Shapiro, S. Renock, E. Arrington et al., “Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology,” Neuropsychopharmacology, vol. 28, no. 8, pp. 1400–1411, 2003. View at Publisher · View at Google Scholar · View at Scopus
  129. P. J. Goodnick and J. M. Jerry, “Aripiprazole: profile on efficacy and safety,” Expert Opinion on Pharmacotherapy, vol. 3, no. 12, pp. 1773–1781, 2002. View at Publisher · View at Google Scholar · View at Scopus
  130. C. A. Farmer and M. G. Aman, “Aripiprazole for the treatment of irritability associated with autism,” Expert Opinion on Pharmacotherapy, vol. 12, no. 4, pp. 635–640, 2011. View at Publisher · View at Google Scholar · View at Scopus
  131. H. Ching and T. Pringsheim, Aripiprazole for Autism Spectrum Disorders (ASD), The Cochrane Library, 2012.
  132. Y.-C. Chang, J. Quan, and J. J. Wood, “Effects of anxiety disorder severity on social functioning in children with autism spectrum disorders,” Journal of Developmental and Physical Disabilities, vol. 24, no. 3, pp. 235–245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  133. J. J. Wood and K. D. Gadow, “Exploring the nature and function of anxiety in youth with autism spectrum disorders,” Clinical Psychology: Science and Practice, vol. 17, no. 4, pp. 281–292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. B. Bandelow, U. Seidler-Brandler, A. Becker, D. Wedekind, and E. Rüther, “Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders,” The World Journal of Biological Psychiatry, vol. 8, no. 3, pp. 175–187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  135. G. M. Soomro, D. Altman, S. Rajagopal, and M. Oakley-Browne, “Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD),” The Cochrane Database of Systematic Reviews, no. 1, Article ID CD001765, 2008. View at Publisher · View at Google Scholar
  136. E. H. Cook Jr. and B. L. Leventhal, “The serotonin system in autism,” Current Opinion in Pediatrics, vol. 8, no. 4, pp. 348–354, 1996. View at Publisher · View at Google Scholar · View at Scopus
  137. B. Devlin, E. H. Cook Jr., H. Coon et al., “Autism and the serotonin transporter: the long and short of it,” Molecular Psychiatry, vol. 10, no. 12, pp. 1110–1116, 2005. View at Publisher · View at Google Scholar · View at Scopus
  138. S. E. Maloney, M. A. Rieger, and J. D. Dougherty, “Identifying essential cell types and circuits in autism spectrum disorders,” International Review of Neurobiology, vol. 113, pp. 61–96, 2013. View at Publisher · View at Google Scholar · View at Scopus
  139. A. Oblak, T. T. Gibbs, and G. J. Blatt, “Reduced serotonin receptor subtypes in a limbic and a neocortical region in autism,” Autism Research, vol. 6, no. 6, pp. 571–583, 2013. View at Publisher · View at Google Scholar · View at Scopus
  140. M. Carrasco, F. R. Volkmar, and M. H. Bloch, “Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias,” Pediatrics, vol. 129, no. 5, pp. e1301–e1310, 2012. View at Publisher · View at Google Scholar · View at Scopus
  141. A. Kolevzon, K. A. Mathewson, and E. Hollander, “Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability,” Journal of Clinical Psychiatry, vol. 67, no. 3, pp. 407–414, 2006. View at Publisher · View at Google Scholar · View at Scopus
  142. P. R. Choudhury, S. Lahiri, and U. Rajamma, “Glutamate mediated signaling in the pathophysiology of autism spectrum disorders,” Pharmacology Biochemistry and Behavior, vol. 100, no. 4, pp. 841–849, 2012. View at Publisher · View at Google Scholar · View at Scopus
  143. S. Coghlan, J. Horder, B. Inkster, M. A. Mendez, D. G. Murphy, and D. J. Nutt, “GABA system dysfunction in autism and related disorders: from synapse to symptoms,” Neuroscience & Biobehavioral Reviews, vol. 36, no. 9, pp. 2044–2055, 2012. View at Publisher · View at Google Scholar · View at Scopus
  144. M. M. Lim, I. F. Bielsky, and L. J. Young, “Neuropeptides and the social brain: potential rodent models of autism,” International Journal of Developmental Neuroscience, vol. 23, no. 2-3, pp. 235–243, 2005. View at Publisher · View at Google Scholar · View at Scopus
  145. C. Modahl, L. Green, D. Fein et al., “Plasma oxytocin levels in autistic children,” Biological Psychiatry, vol. 43, no. 4, pp. 270–277, 1998. View at Publisher · View at Google Scholar · View at Scopus
  146. K. B. Nelson, J. K. Grether, L. A. Croen et al., “Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation,” Annals of Neurology, vol. 49, no. 5, pp. 597–606, 2001. View at Publisher · View at Google Scholar · View at Scopus
  147. S. I. Deutsch, M. R. Urbano, S. A. Neumann, J. A. Burket, and E. Katz, “Cholinergic abnormalities in autism: is there a rationale for selective nicotinic agonist interventions?” Clinical Neuropharmacology, vol. 33, no. 3, pp. 114–120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. P. M. Lippiello, “Nicotinic cholinergic antagonists: a novel approach for the treatment of autism,” Medical Hypotheses, vol. 66, no. 5, pp. 985–990, 2006. View at Publisher · View at Google Scholar · View at Scopus
  149. K. Beauchamp, H. Mutlak, W. R. Smith, E. Shohami, and P. F. Stahel, “Pharmacology of traumatic brain injury: where is the “golden bullet”?” Molecular Medicine, vol. 14, no. 11-12, pp. 731–740, 2008. View at Publisher · View at Google Scholar · View at Scopus
  150. E. Chew and R. D. Zafonte, “Pharmacological management of neurobehavioral disorders following traumatic brain injury—a state-of-the-art review,” Journal of Rehabilitation Research and Development, vol. 46, no. 6, pp. 851–878, 2009. View at Publisher · View at Google Scholar · View at Scopus
  151. D. J. Loane and A. I. Faden, “Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies,” Trends in Pharmacological Sciences, vol. 31, no. 12, pp. 596–604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  152. M. G. Aman, C. J. McDougle, L. Scahill et al., “Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 48, no. 12, pp. 1143–1154, 2009. View at Publisher · View at Google Scholar
  153. S. Margulies and R. Hicks, “The combination therapies for traumatic brain injury workshop l: combination therapies for traumatic brain injury: prospective considerations,” Journal of Neurotrauma, vol. 26, no. 6, pp. 925–939, 2009. View at Publisher · View at Google Scholar